These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels. Takenaka T; Inagaki O; Terai M; Asano M; Kubo K J Pharmacol Exp Ther; 1988 Feb; 244(2):699-708. PubMed ID: 2450201 [TBL] [Abstract][Full Text] [Related]
6. Calcium activation systems in vascular smooth muscle. Golenhofen K Bibl Anat; 1977; (15 Pt 1):123-5. PubMed ID: 597123 [No Abstract] [Full Text] [Related]
7. History of calcium antagonists. Fleckenstein A Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106 [TBL] [Abstract][Full Text] [Related]
11. Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation? Buemi M; Allegra A; Laganà A; Aloisi C; Morabito N; Baldari S; Privitera M; Palella S; Imbesi D; Villari C Int Angiol; 1994 Mar; 13(1):75-7. PubMed ID: 8077802 [TBL] [Abstract][Full Text] [Related]